[Are statins indicated in the prevention of cerebral infarct?]

E Díez-Tejedor1, J A Egido Herrero, A C Gil Núñez

  • 1Hospital Universitario La Paz, Madrid.

Revista De Neurologia
|June 22, 2000
PubMed

Insights

Pravastatin may reduce strokes in patients with ischemic cardiopathy. Further clinical trials are needed, but current evidence suggests its use in stroke prevention for specific patient groups.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Context:

  • Ischemic cardiopathy and stroke share common risk factors, including dyslipidemia and atherosclerosis.
  • Statins, like pravastatin, are known for their lipid-lowering effects and potential pleiotropic benefits.
  • Expert review of existing data on dyslipidemia, stroke epidemiology, and statin mechanisms.

Purpose:

  • To evaluate the potential role of pravastatin in stroke prevention for patients with ischemic cardiopathy.
  • To assess the efficacy of statins in preventing cerebral infarcts in patients with carotid artery stenosis.
  • To discuss the mechanism of action of statins in this context.

Summary:

  • Studies suggest pravastatin use in ischemic cardiopathy may reduce stroke incidence.
  • Expert panel reviewed data on dyslipidemias, stroke epidemiology, and statin effects on cerebral infarcts.
  • Pravastatin is recommended for primary stroke prevention in atheromatous stroke patients, those with stroke and hypercholesterolemia, and carotid stenosis.

Impact:

  • Pravastatin may offer a therapeutic option for primary stroke prevention in specific high-risk populations.
  • Highlights the need for further clinical trials to confirm pravastatin's role in stroke prevention.
  • Informs clinical practice regarding statin use in patients with cerebrovascular and cardiovascular risk factors.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.